Rapidly fatal HTLV-1-associated T-cell leukemia/lymphoma in a patient with SLE

Nature Reviews Rheumatology

Volumn 5, Issue 5, 2009, Pages 283-287

  Fritsch Stork, Ruth D E ^a   Leguit, Roos J ^a   Derksen, Ronald H W M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; GLUCOCORTICOID; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PREDNISONE;

ARTICLE; BLOOD; CASE REPORT; DRUG COMBINATION; FATALITY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE DEFICIENCY; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; SYSTEMIC LUPUS ERYTHEMATOSUS; T CELL LEUKEMIA;

AZATHIOPRINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG THERAPY, COMBINATION; FATAL OUTCOME; FEMALE; GLUCOCORTICOIDS; HTLV-I ANTIBODIES; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PREDNISONE;

EID: 67650351333     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.49     Document Type: Article

References (15)

1. Bernatsky, S. et al. Non-Hodgkin's lymphoma in systemic lupus erythematosus. Ann. Rheum. Dis. 64, 1507-1509 (2005).
2. Ekstrom, S. K. et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 111, 4029-4038 (2008).
3. Bernatsky, S. et al. Mortality in systemic lupus erythematosus. Arthritis Rheum. 54, 2550-2557 (2006).
4. Manns, A., Hisada, M. & La Grenade, L. Human T-lymphotropic virus type I infection. Lancet 353, 1951-1958 (1999).
5. Mueller, N., Okayama, A., Stuver, S. & Tachibana, N. Findings from the Miyazaki Cohort Study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (Suppl. 1), S2-S7 (1996).
6. Wiktor, S. Z. et al. Mother-to-child transmission of human T-cell lymphotropic virus type I associated with prolonged breast-feeding. J. Hum. Virol. 1, 37-44 (1997).
7. Kondo, T. et al. Age- and sex-specific cumulative rate and risk of ATLL for HTLV-I carriers. Int. J. Cancer 43, 1061-1064 (1989).
8. Hanchard, B. Adult T-cell leukaemia/lymphoma in Jamaica: 1986-1995. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 13 (Suppl. 1), S20-S25 (1996).
9. Shimoyama, M. Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87). Br. J. Haematol. 79, 428-437 (1991).
10. Ciminale, V. et al. Unusual CD4+CD8+ phenotype in a Greek patient diagnosed with adult T-cell leukemia positive for human T-cell leukemia virus type I (HTLV-I). Leuk. Res. 24, 353-358 (2000).
11. Kamihira, S. et al. Phenotypic diversity and prognosis of adult T-cell leukemia. Leuk. Res. 16, 435-441 (1992).
12. Hoshida, Y. et al. Lymphoproliferative disorders in renal transplant patients in Japan. Int. J. Cancer 91, 869-875 (2001).
13. Tamaki, H. & Matsuoka, M. Donor-derived T-cell leukemia after bone marrow transplantation. N. Engl. J. Med. 354, 1758-1759 (2006).
14. Au, W. Y. et al. Therapy-related lymphomas in patients with autoimmune diseases after treatment with disease-modifying anti- rheumatic drugs. Am. J. Hematol. 81, 5-11 (2006).
15. Ishitsuka, K. & Tamura, K. Treatment of adult T-cell leukaemia/lymphoma: past, present and future. Eur. J. Haematol. 80, 185-196 (2008).